Rendu Overview

  • Founded
  • 2007

  • Status
  • Public

  • Employees
  • 314

  • Stock Symbol
  • 688193

Stock Symbol
  • Share Price
  • $7.77

  • (As of Thursday Closing)

Rendu General Information


Shanghai Rendu Biotechnology Co Ltd provides solutions for accurate diagnosis, effective prevention and control, as well as personalized diagnosis and treatment of pathogens in the areas of reproduction, respiration, digestion, blood, food, and environmental safety.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Stock Exchange
Primary Office
  • No. B, Building 15
  • No. 528, Ruiqing Road, East District, Zhangjiang Hi-Tech Park
  • Shanghai, 201201
  • China
+86 021 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rendu Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.77 $7.88 $6.23 - $10.70 $315M 40M 248K $0.18

Rendu Financials Summary

In Thousands,
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 133,775
Revenue 47,118 45,269 36,173 14,352
EBITDA 7,125 12,534 10,951 1,179
Net Income 5,668 10,007 8,884 541
Total Assets 152,476 59,398 47,570 26,736
Total Debt 1,136 626 588 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Rendu Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rendu‘s full profile, request access.

Request a free trial

Rendu Patents

Rendu Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200292565-A1 Automated nucleic acid sample preparation, detection, and analysis system Pending 11-Oct-2017 0000000000
JP-2021508250-A Automatic nucleic acid sample preparation, detection and analysis system Pending 11-Oct-2017 00000000000 0

Rendu Executive Team (1)

Name Title Board Seat Contact Info
Jinliang Ju Ph.D Chairman & Chief Scientific Officer & Founder
To view Rendu’s complete executive team members history, request access »

Rendu Board Members (2)

Name Representing Role Since
Jinliang Ju Ph.D Rendu Chairman & Chief Scientific Officer & Founder 000 0000
William Hu Qiming Venture Partners Board Member 000 0000
To view Rendu’s complete board members history, request access »

Rendu Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial